Odyssey Health (ODYY) Receivables - Other (2022 - 2024)

Odyssey Health (ODYY) posted quarterly Receivables - Other of -$268411.0 for Q1 2024, down 1954.95% quarter-over-quarter from $14470.0 in Q4 2023.

Odyssey Health (ODYY) Receivables - Other (2022 - 2024) Analysis & Trends

Odyssey Health's Receivables - Other history runs 3 years deep, the most recent figure standing at -$268411.0 for Q1 2024.

In Q1 2024, Receivables - Other changed N/A year-over-year to -$268411.0; the TTM figure through Jul 2025 stood at -$268411.0 (down 5.7% YoY), while the FY2025 annual figure was $22625.0, up 108.91% from the prior year.
Receivables - Other for Q1 2024 stood at -$268411.0, down from $14470.0 in the prior quarter.
The five-year high for Receivables - Other was $276566.0 in Q3 2023, with the low at -$268411.0 in Q1 2024.
The 3-year median for Receivables - Other is $20985.0 (2022), against an average of $12531.2.
Peak annual rise in Receivables - Other reached 905.69% in 2023, while the deepest fall reached 905.69% in 2023.
Odyssey Health's Receivables - Other stood at $27500.0 in 2022, then sank by 47.38% to $14470.0 in 2023, then slumped by 1954.95% to -$268411.0 in 2024.
Business Quant data shows ODYY's Receivables - Other at -$268411.0 in Q1 2024, $14470.0 in Q4 2023, and $276566.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.49 Bn	193.88 Bn	7.27 Bn
2	Stryker	127.80 Bn	124.32 Bn	4.50 Bn
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn
4	Boston Scientific	73.58 Bn	73.04 Bn	3.85 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.66 Bn	2.18 Bn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn
10	Odyssey Health	1.01 Mn	711,880.61	-

Download Data